Suzuki et al. demonstrated that CD56 expression in ALCL was associated with a poor prognosis, while their study had an ill-defined mixture of adult and pediatric, ALK-positive and ALK-negative cases, as Dunphy et al. concluded [5, 7]. The gene discussed is NCAM1; the disease is anaplastic large cell lymphoma.